FDA clears first medical device treatment for childhood ADHD
August 27, 2019 The prescription-only treatment — NeuroSigma’s Monarch external trigeminal nerve stimulation system — is designed for children who are currently not taking any medications. About the size of a cellphone, the device delivers a mild electrical pulse to a wired patch placed on the patient’s forehead while sleeping. By stimulating the branches of … Read more